204 related articles for article (PubMed ID: 34791250)
1. The F-box protein, FBXO7, is required to maintain chromosome stability in humans.
Palmer MCL; Neudorf NM; Farrell AC; Razi T; Lichtensztejn Z; McManus KJ
Hum Mol Genet; 2022 May; 31(9):1471-1486. PubMed ID: 34791250
[TBL] [Abstract][Full Text] [Related]
2. Reduced
Neudorf NM; Thompson LL; Lichtensztejn Z; Razi T; McManus KJ
Cells; 2022 Nov; 11(23):. PubMed ID: 36496990
[TBL] [Abstract][Full Text] [Related]
3. Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells.
Bungsy M; Palmer MCL; Jeusset LM; Neudorf NM; Lichtensztejn Z; Nachtigal MW; McManus KJ
Cancer Lett; 2021 Mar; 500():194-207. PubMed ID: 33290867
[TBL] [Abstract][Full Text] [Related]
4. Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.
Lepage CC; Palmer MCL; Farrell AC; Neudorf NM; Lichtensztejn Z; Nachtigal MW; McManus KJ
Br J Cancer; 2021 May; 124(10):1699-1710. PubMed ID: 33731859
[TBL] [Abstract][Full Text] [Related]
5. Reduced
Thompson LL; Baergen AK; Lichtensztejn Z; McManus KJ
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32106628
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and crystallization of the FP domain of the human F-box protein Fbxo7.
Shang J; Wang G; Yang Y; Huang X; Du Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Oct; 69(Pt 10):1097-9. PubMed ID: 24100556
[TBL] [Abstract][Full Text] [Related]
7. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
[TBL] [Abstract][Full Text] [Related]
8. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
[TBL] [Abstract][Full Text] [Related]
9. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
Randle SJ; Laman H
Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Assessment of Genetic and Epigenetic Alterations Identifies Frequent Variations Impacting Six Prototypic SCF Complex Members.
Campos Gudiño R; Farrell AC; Neudorf NM; McManus KJ
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008511
[TBL] [Abstract][Full Text] [Related]
11. CIN By WNT: growth pathways, mitotic control and chromosomal instability in cancer.
Hadjihannas MV; Behrens J
Cell Cycle; 2006 Sep; 5(18):2077-81. PubMed ID: 16969101
[TBL] [Abstract][Full Text] [Related]
12. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex.
Wang Q; Crnković V; Preisinger C; Stegmüller J
Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of FBXO7 and its role in human diseases.
Zhong Y; Li J; Ye M; Jin X
Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
[TBL] [Abstract][Full Text] [Related]
14. A Competitive binding mechanism between Skp1 and exportin 1 (CRM1) controls the localization of a subset of F-box proteins.
Nelson DE; Laman H
J Biol Chem; 2011 Jun; 286(22):19804-15. PubMed ID: 21378169
[TBL] [Abstract][Full Text] [Related]
15. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
17. Aberrant SKP1 Expression: Diverse Mechanisms Impacting Genome and Chromosome Stability.
Thompson LL; Rutherford KA; Lepage CC; McManus KJ
Front Cell Dev Biol; 2022; 10():859582. PubMed ID: 35345853
[TBL] [Abstract][Full Text] [Related]
18. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers.
Nishida N; Nagasaka T; Kashiwagi K; Boland CR; Goel A
Cancer Biol Ther; 2007 Apr; 6(4):525-33. PubMed ID: 17457043
[TBL] [Abstract][Full Text] [Related]
19. Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.
Joseph S; Vingill S; Jahn O; Fledrich R; Werner HB; Katona I; Möbius W; Mitkovski M; Huang Y; Weis J; Sereda MW; Schulz JB; Nave KA; Stegmüller J
J Neurosci; 2019 Jul; 39(28):5606-5626. PubMed ID: 31085610
[TBL] [Abstract][Full Text] [Related]
20. Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interaction.
Shang J; Wang G; Yang Y; Huang X; Du Z
Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):155-64. PubMed ID: 24419388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
